← back to search

Q. Liu

Hong Kong Polytechnic University · HK

Area of research

Cancer Research · Oncology

Research interest

Research interests include Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, and Atmospheric chemistry and aerosols.

h-index

5

citations

303

works

11

NIH funding

—

primary concept

Medicine

email

✉ Find email ↗

Recent publications

ESO–ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)

Annals of Oncology 2022cited by 210position: middledoi

LBA19 Pyrotinib or placebo in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer (PHILA): A randomized phase III trial

Annals of Oncology 2022cited by 18position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

S. Wang · Hebei Medical University1 papers (2022–2022)Virpi Sulosaari · Cancer Care Ontario1 papers (2022–2022)Shani Paluch–Shimon · Hebrew University of Jerusalem1 papers (2022–2022)W. Li · Ningbo University1 papers (2022–2022)Giuseppe Curigliano · Istituti di Ricovero e Cura a Carattere Scientifico1 papers (2022–2022)Yue Teng · Fudan University1 papers (2022–2022)— · 1 papers (2022–2022)Fedro A. Peccatori · European Institute of Oncology1 papers (2022–2022)Binghe Xu · Chinese Academy of Medical Sciences & Peking Union Medical College1 papers (2022–2022)Oreste Gentilini · Vita-Salute San Raffaele University1 papers (2022–2022)Bhawna Sirohi · Cancer Research UK1 papers (2022–2022)Tao Sun · Shandong University1 papers (2022–2022)Zhong Sheng Tong · Anhui Medical University1 papers (2022–2022)Tao Luo · Guangxi Medical University1 papers (2022–2022)Philip Poortmans · Ziekenhuisnetwerk Antwerpen Stuivenberg1 papers (2022–2022)Fátima Cardoso · Banco de Portugal1 papers (2022–2022)Nadia Harbeck · Universität Bayern1 papers (2022–2022)G. Bianchi-Micheli · Laboratory for Biomedical Neurosciences1 papers (2022–2022)Omalkhair Abulkhair · Riyadh Armed Forces Hospital1 papers (2022–2022)Hatem A. Azim · Cairo University1 papers (2022–2022)